Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,963 | -14,740 | -8,556 | -2,781 | -9,611 |
| Depreciation Amortization | 31 | 7 | 4 | 2 | 1 |
| Accounts payable and accrued liabilities | 609 | 1,654 | 563 | 765 | 37 |
| Other Working Capital | -6,510 | -762 | 428 | -1,019 | 974 |
| Other Operating Activity | 1,434 | -465 | -219 | -742 | 740 |
| Operating Cash Flow | $-27,399 | $-14,306 | $-7,780 | $-3,775 | $-7,859 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -113,253 | N/A | N/A | N/A | N/A |
| PPE Investments | -181 | -96 | -40 | -40 | 0 |
| Investing Cash Flow | $-113,434 | $-96 | $-40 | $-40 | $0 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | 2,500 |
| Common Stock Issued | 126,945 | 127,195 | N/A | N/A | 5 |
| Other Financing Activity | 63,512 | 63,512 | 62,397 | 7,883 | 6,413 |
| Financing Cash Flow | $190,457 | $190,707 | $62,397 | $7,883 | $8,918 |
| Beginning Cash Position | 4,573 | 4,573 | 4,573 | 4,573 | 3,514 |
| End Cash Position | 54,197 | 180,878 | 59,150 | 8,641 | 4,573 |
| Net Cash Flow | $49,624 | $176,305 | $54,577 | $4,068 | $1,059 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,399 | -14,306 | -7,780 | -3,775 | -7,859 |
| Capital Expenditure | -181 | -96 | -40 | -40 | N/A |
| Free Cash Flow | -27,580 | -14,402 | -7,820 | -3,815 | -7,859 |